Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Tshilenge KT"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł :
Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates.
Autorzy :
García-Huerta P; Faculty of Medicine, Biomedical Neuroscience Institute, University of Chile, Santiago, Chile.; Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Sector B, Second Floor, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile.
Troncoso-Escudero P; Faculty of Medicine, Biomedical Neuroscience Institute, University of Chile, Santiago, Chile.; Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Sector B, Second Floor, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile.; Center for Integrative Biology, Faculty of Sciences, University Mayor, Santiago, Chile.
Wu D; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Thiruvalluvan A; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Cisternas-Olmedo M; Faculty of Medicine, Biomedical Neuroscience Institute, University of Chile, Santiago, Chile.; Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.; Center for Integrative Biology, Faculty of Sciences, University Mayor, Santiago, Chile.
Henríquez DR; Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.; Department of Cell Biology, Faculty of Sciences, University of Chile, Santiago, Chile.
Plate L; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
Chana-Cuevas P; Faculty of Medical Sciences, University of Santiago de Chile, Santiago, Chile.
Saquel C; Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.; Center for Integrative Biology, Faculty of Sciences, University Mayor, Santiago, Chile.
Thielen P; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, 02115, USA.
Longo KA; Proteostasis Therapeutics, Cambridge, MA, USA.
Geddes BJ; Proteostasis Therapeutics, Cambridge, MA, USA.
Lederkremer GZ; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; George Wise Faculty of Life Sciences, School of Molecular Cell Biology and Biotechnology, Tel Aviv University, Tel Aviv, Israel.
Sharma N; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; George Wise Faculty of Life Sciences, School of Molecular Cell Biology and Biotechnology, Tel Aviv University, Tel Aviv, Israel.
Shenkman M; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.; George Wise Faculty of Life Sciences, School of Molecular Cell Biology and Biotechnology, Tel Aviv University, Tel Aviv, Israel.
Naphade S; Buck Institute for Research on Aging, Novato, CA, 94945, USA.
Sardi SP; Rare and Neurological Diseases Therapeutic Area, Sanofi, 49 New York Avenue, Framingham, MA, 01701, USA.
Spichiger C; Faculty of Sciences, Institute of Biochemistry and Microbiology, University Austral of Chile, Valdivia, Chile.
Richter HG; Faculty of Medicine, Institute of Anatomy, Histology and Pathology, University Austral of Chile, Valdivia, Chile.
Court FA; Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.; Center for Integrative Biology, Faculty of Sciences, University Mayor, Santiago, Chile.; Buck Institute for Research on Aging, Novato, CA, 94945, USA.
Tshilenge KT; Buck Institute for Research on Aging, Novato, CA, 94945, USA.
Ellerby LM; Buck Institute for Research on Aging, Novato, CA, 94945, USA.
Wiseman RL; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
Gonzalez-Billault C; Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.; Department of Cell Biology, Faculty of Sciences, University of Chile, Santiago, Chile.; Buck Institute for Research on Aging, Novato, CA, 94945, USA.
Bergink S; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Vidal RL; Faculty of Medicine, Biomedical Neuroscience Institute, University of Chile, Santiago, Chile. .; Center for Geroscience, Brain Health and Metabolism, Santiago, Chile. .; Center for Integrative Biology, Faculty of Sciences, University Mayor, Santiago, Chile. .
Hetz C; Faculty of Medicine, Biomedical Neuroscience Institute, University of Chile, Santiago, Chile. .; Center for Geroscience, Brain Health and Metabolism, Santiago, Chile. .; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Sector B, Second Floor, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile. .; Buck Institute for Research on Aging, Novato, CA, 94945, USA. .
Pokaż więcej
Źródło :
Acta neuropathologica [Acta Neuropathol] 2020 Nov; Vol. 140 (5), pp. 737-764. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
FOXO3 targets are reprogrammed as Huntington's disease neural cells and striatal neurons face senescence with p16 increase.
Autorzy :
Voisin J; Centre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Farina F; Centre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Naphade S; Buck Institute for Research on Aging, Novato, CA, USA.
Fontaine M; Centre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Tshilenge KT; Buck Institute for Research on Aging, Novato, CA, USA.
Galicia Aguirre C; Buck Institute for Research on Aging, Novato, CA, USA.
Lopez-Ramirez A; Buck Institute for Research on Aging, Novato, CA, USA.
Dancourt J; Centre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Ginisty A; Centre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Sasidharan Nair S; Centre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Lakshika Madushani K; Buck Institute for Research on Aging, Novato, CA, USA.
Zhang N; Buck Institute for Research on Aging, Novato, CA, USA.
Lejeune FX; Centre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Verny M; Centre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Campisi J; Buck Institute for Research on Aging, Novato, CA, USA.; Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Ellerby LM; Buck Institute for Research on Aging, Novato, CA, USA.
Neri C; Centre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Pokaż więcej
Źródło :
Aging cell [Aging Cell] 2020 Nov; Vol. 19 (11), pp. e13226. Date of Electronic Publication: 2020 Nov 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Nuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D 1 Receptor Signaling.
Autorzy :
Cirnaru MD; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Melis C; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Fanutza T; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Naphade S; The Buck Institute for Research on Aging, Novato, California 94945.
Tshilenge KT; The Buck Institute for Research on Aging, Novato, California 94945.
Muntean BS; Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida 33458.
Martemyanov KA; Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida 33458.
Plotkin JL; Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York 11794.
Ellerby LM; The Buck Institute for Research on Aging, Novato, California 94945.
Ehrlich ME; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York 10029 .
Pokaż więcej
Źródło :
ENeuro [eNeuro] 2019 Oct 10; Vol. 6 (5). Date of Electronic Publication: 2019 Oct 10 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Corpus Striatum/*metabolism
Neurons/*metabolism
Nuclear Receptor Subfamily 4, Group A, Member 1/*biosynthesis
Receptors, Dopamine D1/*biosynthesis
Signal Transduction/*physiology
Animals ; Animals, Newborn ; Cells, Cultured ; Cocaine/pharmacology ; Corpus Striatum/cytology ; Corpus Striatum/drug effects ; Dopamine Uptake Inhibitors/pharmacology ; Humans ; Locomotion/drug effects ; Locomotion/physiology ; Male ; Mice ; Mice, Knockout ; Mice, Transgenic ; Neurons/drug effects ; Nuclear Receptor Subfamily 4, Group A, Member 1/deficiency ; Signal Transduction/drug effects
Czasopismo naukowe
Tytuł :
Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.
Autorzy :
Naphade S; Buck Institute for Research on Aging, 8001 Redwood Blvd, Novato, CA, 94945, USA.
Tshilenge KT; Buck Institute for Research on Aging, 8001 Redwood Blvd, Novato, CA, 94945, USA.
Ellerby LM; Buck Institute for Research on Aging, 8001 Redwood Blvd, Novato, CA, 94945, USA. .
Pokaż więcej
Źródło :
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2019 Oct; Vol. 16 (4), pp. 979-998.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Huntington Disease/*genetics
Huntington Disease/*metabolism
Induced Pluripotent Stem Cells/*metabolism
Peptides/*genetics
Peptides/*metabolism
Trinucleotide Repeat Expansion/*physiology
Animals ; Brain/metabolism ; Brain/pathology ; Humans ; Huntington Disease/pathology ; Induced Pluripotent Stem Cells/pathology ; Neurodegenerative Diseases/genetics ; Neurodegenerative Diseases/metabolism ; Neurodegenerative Diseases/pathology ; Neurons/metabolism ; Neurons/pathology
Czasopismo naukowe
Tytuł :
Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells.
Autorzy :
Peters C; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.; Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.
Paget M; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.; Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.
Tshilenge KT; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Saha D; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA.
Antoszczyk S; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Baars A; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Frost T; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.; Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.
Martuza RL; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA.
Wakimoto H; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA.
Rabkin SD; Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA .; Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2018 Jul 17; Vol. 92 (15). Date of Electronic Publication: 2018 Jul 17 (Print Publication: 2018).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Deletion*
Brain Neoplasms/*virology
Glioblastoma/*virology
Neoplastic Stem Cells/*virology
Simplexvirus/*physiology
Viral Proteins/*genetics
Animals ; Brain Neoplasms/metabolism ; Brain Neoplasms/therapy ; Cell Culture Techniques/methods ; Cell Line, Tumor ; Chlorocebus aethiops ; Glioblastoma/metabolism ; Glioblastoma/therapy ; Herpes Simplex/genetics ; Neoplastic Stem Cells/metabolism ; Oncolytic Viruses/genetics ; Oncolytic Viruses/physiology ; RNA-Binding Proteins/metabolism ; Simplexvirus/genetics ; Vero Cells ; Viral Proteins/metabolism ; Virus Replication
Czasopismo naukowe
Tytuł :
Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina.
Autorzy :
Ameline B; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Tshilenge KT; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Weber M; CHU de Nantes, Service d'Ophtalmologie, Nantes, France.
Biget M; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Libeau L; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.; CHU de Nantes, Service d'Ophtalmologie, Nantes, France.
Caplette R; INSERM, U968, Paris, France.; Sorbonne Universités, UPMC Université de Paris 06, UMR_S 968, Institut de la Vision, Paris, France.; CNRS, UMR_7210, Paris, France.
Mendes-Madeira A; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Provost N; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Guihal C; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Picaud S; INSERM, U968, Paris, France.; Sorbonne Universités, UPMC Université de Paris 06, UMR_S 968, Institut de la Vision, Paris, France.; CNRS, UMR_7210, Paris, France.
Moullier P; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Pichard V; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Cronin T; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Isiegas C; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Pokaż więcej
Źródło :
Gene therapy [Gene Ther] 2017 Nov; Vol. 24 (11), pp. 735-741. Date of Electronic Publication: 2017 Sep 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Channelrhodopsins/*physiology
Retina/*metabolism
Retinal Degeneration/*therapy
Rod Opsins/*physiology
Animals ; Channelrhodopsins/genetics ; Channelrhodopsins/metabolism ; Dependovirus/genetics ; Disease Models, Animal ; Dogs ; Electroretinography/methods ; Eye Proteins/genetics ; Gene Expression Regulation/genetics ; Gene Transfer Techniques ; Genetic Therapy/methods ; Genetic Vectors/genetics ; HEK293 Cells ; Humans ; Leber Congenital Amaurosis/therapy ; Retina/physiology ; Rod Opsins/genetics ; Rod Opsins/metabolism ; Vision, Ocular/physiology
Czasopismo naukowe
Tytuł :
Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman Primates.
Autorzy :
Tshilenge KT; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Ameline B; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Weber M; 2 CHU de Nantes, Service d'Ophtalmologie, Nantes, France.
Mendes-Madeira A; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Nedellec S; 3 Cellular and Tissular Imaging Core Facility of Nantes University, SFR Santé Francois Bonamy INSERM UMS016/CNRS UMS3556, Nantes, France .
Biget M; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Provost N; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Libeau L; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Blouin V; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Deschamps JY; 4 Emergency and Critical Care Unit, ONIRIS, Nantes-Atlantic College of Veterinary Medicine Food Science and Engineering, Nantes, France .
Le Meur G; 2 CHU de Nantes, Service d'Ophtalmologie, Nantes, France.
Colle MA; 5 UMR 703 PAnTher INRA/ONIRIS, Nantes-Atlantic College of Veterinary Medicine Food Science and Engineering, Nantes, France .
Moullier P; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.; 6 Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida , Gainesville, Florida.
Pichard V; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Rolling F; 1 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Pokaż więcej
Źródło :
Human gene therapy methods [Hum Gene Ther Methods] 2016 Jun; Vol. 27 (3), pp. 122-34.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Therapy*
Retinal Ganglion Cells*
Genetic Vectors/*therapeutic use
Animals ; Dependovirus/genetics ; Dogs ; Gene Transfer Techniques ; Green Fluorescent Proteins ; Humans ; Intravitreal Injections ; Macaca ; Retina/pathology ; Retina/transplantation ; Transduction, Genetic ; Vitrectomy
Czasopismo naukowe
Tytuł :
AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs.
Autorzy :
Pichard V; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Provost N; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Mendes-Madeira A; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Libeau L; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Hulin P; Cellular and Tissular Imaging Core Facility of Nantes University, SFR Santé Francois Bonamy, INSERM UMS016/CNRS UMS3556, Nantes, France.
Tshilenge KT; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Biget M; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Ameline B; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Deschamps JY; Emergency and Critical Care Unit, ONIRIS, Nantes-Atlantic College of Veterinary Medicine, Food Science and Engineering, Nantes, France.
Weber M; CHU de Nantes, Service d'Ophtalmologie, Nantes, France.
Le Meur G; CHU de Nantes, Service d'Ophtalmologie, Nantes, France.
Colle MA; UMR 703 PAnTher INRA/ONIRIS, Nantes-Atlantic College of Veterinary Medicine, Food Science and Engineering, Nantes, France.
Moullier P; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.; Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, Florida, USA.
Rolling F; Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France.
Pokaż więcej
Źródło :
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2016 May; Vol. 24 (5), pp. 867-76. Date of Electronic Publication: 2016 Feb 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cyclic Nucleotide Phosphodiesterases, Type 6/*genetics
Genetic Therapy/*methods
Retinal Degeneration/*therapy
Retinal Rod Photoreceptor Cells/*pathology
Animals ; Cyclic Nucleotide Phosphodiesterases, Type 6/deficiency ; Dependovirus/genetics ; Disease Models, Animal ; Dogs ; Genetic Vectors/administration & dosage ; Humans ; Retina/physiopathology ; Retinal Degeneration/genetics ; Retinal Degeneration/pathology
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies